On Tuesday, Capricor Therapeutics Inc (NASDAQ: CAPR) was -7.37% drop from the session before settling in for the closing price of $19.54. A 52-week range for CAPR has been $2.72 – $23.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 339.72% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at -50.00%. With a float of $37.83 million, this company’s outstanding shares have now reached $45.46 million.
In an organization with 102 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 95.31%, operating margin of -109.7%, and the pretax margin is -102.93%.
Capricor Therapeutics Inc (CAPR) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Capricor Therapeutics Inc stocks. The insider ownership of Capricor Therapeutics Inc is 16.78%, while institutional ownership is 14.19%. The most recent insider transaction that took place on Sep 20 ’24, was worth 14,999,998. In this transaction 10% Owner of this company bought 2,798,507 shares at a rate of $5.36, taking the stock ownership to the 7,090,351 shares.
Capricor Therapeutics Inc (CAPR) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 6/30/2024, it has been observed that the corporation posted -0.25 earnings per share (EPS) during the time that was better than consensus figure (set at -0.29) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -50.00% per share during the next fiscal year.
Capricor Therapeutics Inc (NASDAQ: CAPR) Trading Performance Indicators
You can see what Capricor Therapeutics Inc (CAPR) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.37. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 30.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.93, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -0.81 in one year’s time.
Technical Analysis of Capricor Therapeutics Inc (CAPR)
Let’s dig in a bit further. During the last 5-days, its volume was 1.04 million. That was inferior than the volume of 1.14 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 31.02%. Additionally, its Average True Range was 1.81.
During the past 100 days, Capricor Therapeutics Inc’s (CAPR) raw stochastic average was set at 73.34%, which indicates a significant increase from 11.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.86% in the past 14 days, which was lower than the 129.45% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.38, while its 200-day Moving Average is $7.38. However, in the short run, Capricor Therapeutics Inc’s stock first resistance to watch stands at $19.09. Second resistance stands at $20.07. The third major resistance level sits at $20.66. If the price goes on to break the first support level at $17.52, it is likely to go to the next support level at $16.93. The third support level lies at $15.95 if the price breaches the second support level.
Capricor Therapeutics Inc (NASDAQ: CAPR) Key Stats
There are 45,406K outstanding shares of the company, which has a market capitalization of 822.88 million. As of now, sales total 25,180 K while income totals -22,290 K. Its latest quarter income was 3,970 K while its last quarter net income were -11,000 K.
